Evidence map›Paper›PMID 39257281›Full record

ArticleJournal of the Royal Society, Interface2024

A novel, scenario-based approach to comparing non-pharmaceutical intervention strategies across nations.

Justin M Calabrese, Lennart Schüler, Xiaoming Fu, Erik Gawel, Heinrich Zozmann, Jan Bumberger, Martin Quaas, Gerome Wolf, Sabine Attinger

Abstract read
In one paragraph

Article in Journal of the Royal Society, Interface, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Justin M Calabrese *Center for Advanced Systems Understanding (CASUS), Untermarkt 20 , Görlitz 02826, Germany.ORCID 0000-0003-0575-6408
Lennart Schüler *Center for Advanced Systems Understanding (CASUS), Untermarkt 20 , Görlitz 02826, Germany.ORCID 0000-0001-9362-1372
Xiaoming FuCenter for Advanced Systems Understanding (CASUS), Untermarkt 20 , Görlitz 02826, Germany.
Erik GawelDepartment of Economics, UFZ-Helmholtz Centre for Environmental Research , Leipzig, Germany.
Heinrich ZozmannDepartment of Economics, UFZ-Helmholtz Centre for Environmental Research , Leipzig, Germany.
Jan BumbergerResearch Data Management-RDM, UFZ-Helmholtz Centre for Environmental Research , Leipzig, Germany.
Martin QuaasInstitute for Infrastructure and Resources Management, Leipzig University , Leipzig, Germany.
Gerome Wolfifo Institute-Leibniz Institute for Economic Research , Munich, Germany.
Sabine AttingerDepartment of Computational Hydrosystems, UFZ-Helmholtz Centre for Environmental Research , Leipzig, Germany.

Funding

Bundesministerium für Bildung und ForschungHelmholtz-GemeinschaftSächsisches Staatsministerium für Wissenschaft und Kunst
6 · The paper itself

Abstract

Comparing COVID-19 response strategies across nations is a key step in preparing for future pandemics. Conventional comparisons, which rank individual non-pharmaceutical intervention (NPI) effects, are limited by: (i) a focus on epidemiological outcomes; (ii) NPIs typically being applied as packages of interventions; and (iii) different political, economic and social conditions among nations. Here, we develop a coupled epidemiological-behavioural-macroeconomic model that can transfer NPI effects from a reference nation to a focal nation. This approach quantifies epidemiological, behavioural and economic outcomes while accounting for both packaged NPIs and differing conditions among nations. As a first proof of concept, we take Germany as our focal nation during Spring 2020, and New Zealand and Switzerland as reference nations with contrasting NPI strategies. Our results suggest that, while New Zealand's more aggressive strategy would have yielded modest epidemiological gains in Germany, it would have resulted in substantially higher economic costs while dramatically reducing social contacts. In contrast, Switzerland's more lenient strategy would have prolonged the first wave in Germany, but would also have increased relative costs. More generally, these findings indicate that our approach can provide novel, multifaceted insights on the efficacy of pandemic response strategies, and therefore merits further exploration and development.

Indexed as

COVID-19SARS-CoV-2GermanyHumansNew ZealandPandemicsSwitzerlandbehaviouralCOVID-19epidemiologicalmacroeconomicmodellingnon-pharmaceutical intervention

Identifiers

PMID39257281
PMCPMC11463227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.